ENPP1
Reaktivität: Maus, Ratte
WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro)
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA (1:32000) Western blot (1-3 μg/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-2 μg/mL) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Bertrand, Nitschke, Fuerst, Hermann, Schäfers, Sherwood, Nalesso, Ruether, Rutsch, DellAccio, Pap: "Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calcification in osteoarthritis and trigger osteoarthritic changes in mice." in: Annals of the rheumatic diseases, Vol. 71, Issue 7, pp. 1249-53, (2012) (PubMed).
Meyre, Bouatia-Naji, Tounian, Samson, Lecoeur, Vatin, Ghoussaini, Wachter, Hercberg, Charpentier, Patsch, Pattou, Charles, Tounian, Clément, Jouret, Weill, Maddux, Goldfine, Walley, Boutin, Dina et al.: "Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. ..." in: Nature genetics, Vol. 37, Issue 8, pp. 863-7, (2005) (PubMed).